Chronic Stroke Study Available!

Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery

—an IRB approved clinical study

Listed on (NCT05898334) - click here

An opportunity for chronic stroke patients: First Institute of All Medicines, a non-profit organization, is to conduct a clinical study, which is a double blinded, placebo-controlled, two-group randomized clinical study to verify if patients with chronic stroke can regain the ability of living independently after daily use of a biophoton generator to increase the energy of the brain and other parts of the body.


World’s First Energy Wellness Hotel
139 Pittsburgh Road
Butler, PA 16001

Medical research staff at First Institute of All Medicines will be conducting this study using the research facilities at the Biophoton-powered Tesla MedBed Spa and Wellness center.

Our study participants and their caregiver guests will sleep on a bed powered by biophoton generators.

Study Specifics:


  • Participants: 46 volunteers with chronic stroke.
  • Location: Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001.
  • Duration: 4-6 week live-in study. Non-invasive. Sleep on a bed powered with biophoton generators. Estimated Study Dates: first participant enrolled as of May 2023 and last participant to complete by Nov 2024.
  • Procedures: Sleep nightly on a bed with Tesla BioHealing Biophoton Generators underneath (or placebo) and complete life quality assessments. Health status information will be collected non-invasively by a medical professional. Those volunteers initially placed in the placebo group will be switched to the Treatment group 2 weeks after verifying the placebo effects. They will be treated for 4 weeks as well.
  • Qualification: There will be a qualification process to participate in this study. If you are interested in participating, please click the link below, or use the contact information below to connect with the research team. You are also welcomed to reach out to us if you would like more specific information about participation.
  • Cost: There will be no cost to participate. Please note that we do not reimburse or pay for travel or food. Qualified study participants with a doctor's stroke diagnosis (and their caregivers) are to stay at the Center free of charge for the length of the study.
  • Apply today: The research team at First Institute of All Medicines/FIAM looks forward to hearing from you. You'll find the secure application link below. Also, feel free to have a family member or caregiver assist with your registration process by using our contact information.


Jessica Jackson, Clinical Study Coordinator
First Institute of All Medicines
139 Pittsburgh Road, Butler, PA 16001.

Cell phone: 302-922-2486